McKesson Corporation MCK
866.64
(2.72)
(0.31%)
as of 25 Sep
- Market cap
- $101.8B
- P/E
- 23.1×
Follow MCK
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years
McKesson Corporation (MCK) Total debt
McKesson Corporation's total debt at the end of fiscal 2026 was $11.6B, unchanged from fiscal 2025. At the end of the quarter to 30 June 2026 it was $14.8B. Over the past ten years it has ranged from $7.4B (fiscal 2020) to $15.2B (fiscal 2021); the current reading is higher than 67% of that period. McKesson Corporation ranks 1st of 11 Medical Distribution companies by total debt.
Total debt, annual
Annual
| Period | Total debt | Change |
|---|---|---|
| FY2026 | $11.6B | 3.22% |
| FY2025 | $11.3B | (4.15%) |
| FY2024 | $11.7B | (3.90%) |
| FY2023 | $12.2B | (6.72%) |
| FY2022 | $13.1B | (13.91%) |
| FY2021 | $15.2B | 105.97% |
| FY2020 | $7.4B | (2.74%) |
| FY2019 | $7.6B | (3.62%) |
| FY2018 | $7.9B | (7.78%) |
| FY2017 | $8.5B | 5.31% |
Quarterly
| Period | Total debt | Change |
|---|---|---|
| Jun 2026 | $14.8B | 27.29% |
| Mar 2026 | $11.6B | (0.37%) |
| Dec 2025 | $11.7B | (9.34%) |
| Sep 2025 | $12.9B | (3.86%) |
| 42 more quarters | Free account |
Against its own ten years
Low $7.4B
High $15.2B
Ten-year median
$10.5B
Current reading's percentile
67
Total debt against peers
| Company | Total debt |
|---|---|
| MCK McKesson Corporation | $14.8B |
| COR Cencora, Inc. compare | $11.7B |
| CAH Cardinal Health, Inc. compare | $8.9B |
| HSIC Henry Schein, Inc. compare | $2.4B |
| ACH Accendra Health, Inc. compare | $1.7B |
| FOCL FocalTherics compare | $40.1M |
| YI 111, Inc. Sponsored ADR compare | $37.3M |
| COSM Cosmos Health Inc. compare | $11.8M |
| AHG Akso Health Group Sponsored ADR compare | $4.6M |
What Total debt is
Total Debt tells an investor how much a company has borrowed in all, whether the money is due within a year or later.
Long Term Debt (Total) + Current Part of Debt
More on MCK
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement